Vincent Medical Holdings Limited
Vincent Medical Holdings Limited Fundamental Analysis
Vincent Medical Holdings Limited (1612.HK) shows strong financial fundamentals with a PE ratio of 5.70, profit margin of 11.19%, and ROE of 16.21%. The company generates $0.9B in annual revenue with strong year-over-year growth of 16.46%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 68.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze 1612.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak1612.HK struggles to generate sufficient returns from assets.
Valuation Score
Excellent1612.HK trades at attractive valuation levels.
Growth Score
Excellent1612.HK delivers strong and consistent growth momentum.
Financial Health Score
Excellent1612.HK maintains a strong and stable balance sheet.
Profitability Score
Weak1612.HK struggles to sustain strong margins.
Key Financial Metrics
Is 1612.HK Expensive or Cheap?
P/E Ratio
1612.HK trades at 5.70 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 1612.HK's PEG of 0.40 indicates potential undervaluation.
Price to Book
The market values Vincent Medical Holdings Limited at 0.89 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 3.98 times EBITDA. This is generally considered low.
How Well Does 1612.HK Make Money?
Net Profit Margin
For every $100 in sales, Vincent Medical Holdings Limited keeps $11.19 as profit after all expenses.
Operating Margin
Core operations generate 14.34 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $16.21 in profit for every $100 of shareholder equity.
ROA
Vincent Medical Holdings Limited generates $8.91 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Vincent Medical Holdings Limited generates limited operating cash flow of $84.60M, signaling weaker underlying cash strength.
Free Cash Flow
Vincent Medical Holdings Limited generates weak or negative free cash flow of $-47.15M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.07 in free cash annually.
FCF Yield
1612.HK converts -7.86% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
5.70
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.40
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.89
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.64
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.27
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.96
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.16
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.16
vs 25 benchmark
How 1612.HK Stacks Against Its Sector Peers
| Metric | 1612.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 5.70 | 28.54 | Better (Cheaper) |
| ROE | 16.21% | 738.00% | Weak |
| Net Margin | 11.19% | -43982.00% (disorted) | Strong |
| Debt/Equity | 0.27 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 1.96 | 2806.01 | Neutral |
| ROA | 8.91% | -14624.00% (disorted) | Weak |
1612.HK outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Vincent Medical Holdings Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-19.79%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
-52.18%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
-100.00%
Industry Style: Defensive, Growth, Innovation
Declining